Replies to post #34877 on Revive Therapeutics Ltd (RVVTF)

[tripmcneely]

The study was not designed or approved for the relief of long covid. The timeline to compile or re-work and extend the existing trial will take a length of time that this company cannot afford. Literally. They are burning cash and that last raise won’t sustain a year plus of this.